Back
ESC Premium Access

Risk reduction in HCM: when the gradient is gone, do we still need an ICD?

Session: Risk of sudden death in hypertrophic cardiomyopathy
Topic: Hypertrophic Cardiomyopathy
Speaker: Doctor A. Rigopoulos (Marousi, Athens, GR)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Angelos Rigopoulos

Mitera Hospital, Marousi, Athens (Greece)
7 presentations
0 follower

4 more presentations in this session

Prevention of sudden death in HCM - State of the art

Speaker: Professor P. Elliott (London, GB)

Access
Slides
Video
Thumbnail

Prognostic role of late gadolinium enhancement in patients with low-intermediate 5 year HCM SCD risk score: a multicenter study.

Speaker: Doctor G. Todiere (Pisa, IT)

Access
Abstract
Slides
Video
Thumbnail

Implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy - A nationwide study

Speaker: Doctor A. Tsangaris (Minneapolis, US)

Access
Abstract
Slides
Video
Thumbnail

An international validation study of the 2014 european society of cardiology sudden cardiac death risk prediction model in childhood hypertrophic cardiomyopathy

Speaker: Professor P. Elliott (London, GB)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Risk of sudden death in hypertrophic cardiomyopathy

Speakers: Doctor A. Rigopoulos, Professor P. Elliott, Doctor G. Todiere, Doctor A. Tsangaris, Professor P. Elliott
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb